This study is a multicenter, international, non interventional, retrospective study about SARS-CoV-2 and Multisystem Inflammatory Syndrome (MIS-C) reinfection risk in children.
This study is based to data collection of cases (patients with MIS-C) compare to controls (patients with SARS-CoV-2 infection) occurring between 01 sep 2021 and 30 apr 2022. For this study cases and controls group will be matched for analyses. The main of this study is to evaluate the difference of risk of occurrence of MIS-C between a first SARS-CoV-2 infection and a reinfection with SARS-CoV-2.
Study Type
OBSERVATIONAL
Enrollment
204
ACTIV
Créteil, France
proportion of MIS-C cases occurred after first SARS-CoV-2 infection
Assessment of risk of MIS-C after first SARS-CoV-2 infection
Time frame: 8 months
proportion of MIS-C cases occurred after SARS-CoV-2 reinfection
Assessment of risk of MIS-C after SARS-CoV-2 reinfection
Time frame: 8 months
Proportion of SARS-CoV-2 reinfection after first SARS-CoV-2 infection
Assessment of risk of SARS-CoV-2 reinfection after first SARS-CoV-2 infection
Time frame: 8 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.